Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Crohn's Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06958536
What this trial is testing

Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Who this might be right for
Crohn's Disease
Sanofi 99
Testing effectiveness (Phase 2)Study completedNCT00294112
What this trial is testing

Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease

Who this might be right for
Crohn's Disease
Mesoblast, Inc. 10
Not applicableActive Not RecruitingNCT05930275
What this trial is testing

Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.

Who this might be right for
Crohn's Disease
AbbVie 1,200
Large-scale testing (Phase 3)Looking for participantsNCT06819891
What this trial is testing

Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohns Disease
Hoffmann-La Roche 425
Testing effectiveness (Phase 2)Looking for participantsNCT07697456
What this trial is testing

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn's DiseaseUlcerative Colitis
AbbVie 2,000
Large-scale testing (Phase 3)Ended earlyNCT03961815
What this trial is testing

Open-label Extension Study of Brazikumab in Crohn's Disease

Who this might be right for
Crohn's DiseaseIBD
AstraZeneca 18
Large-scale testing (Phase 3)Ended earlyNCT01536418
What this trial is testing

An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
GlaxoSmithKline 255
Testing effectiveness (Phase 2)WithdrawnNCT05057273
What this trial is testing

Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease

Who this might be right for
Crohn's Disease
NImmune Biopharma
Testing effectiveness (Phase 2)Study completedNCT00234741
What this trial is testing

Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Synta Pharmaceuticals Corp. 12
Large-scale testing (Phase 3)Looking for participantsNCT07184931
What this trial is testing

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Sanofi 980
Not applicableStudy completedNCT03532932
What this trial is testing

Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice

Who this might be right for
Colitis, UlcerativeCrohn DiseaseInflammatory Bowel Diseases
Takeda 1,990
Large-scale testing (Phase 3)Study completedNCT00552058
What this trial is testing

Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

Who this might be right for
Crohn Disease
UCB Pharma 439
Post-approval studies (Phase 4)Looking for participantsNCT07663526
What this trial is testing

Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®

Who this might be right for
Crohn's Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06456593
What this trial is testing

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohn Disease
Abivax S.A. 212
Not applicableStudy completedNCT01759264
What this trial is testing

An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)

Who this might be right for
Crohn's Disease
AbbVie (prior sponsor, Abbott) 101
Testing effectiveness (Phase 2)Looking for participantsNCT07483073
What this trial is testing

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Who this might be right for
Colitis, UlcerativeCrohn Disease
Eli Lilly and Company 60
Testing effectiveness (Phase 2)Looking for participantsNCT03167437
What this trial is testing

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

Who this might be right for
Crohn's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 35
Testing effectiveness (Phase 2)Study completedNCT00267722
What this trial is testing

Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease

Who this might be right for
Crohn's Disease
Facet Biotech 18
Large-scale testing (Phase 3)Study completedNCT03782376
What this trial is testing

Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen-Cilag Ltd. 215
Testing effectiveness (Phase 2)Study completedNCT00603616
What this trial is testing

Induction of Clinical Response Using Rifaximin in Crohn's Disease

Who this might be right for
Crohn's Disease
Scott Lee 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation